삼익제약
8,360KRWMarket close of 10/21 (Wed)
Up +2.58%+210KRWMarket close of 10/21 (Wed)
- Open
- 8,260
- High
- 9,270
- Low
- 8,050
- Day range
- Day range low 8,050 high 9,270, open 8,260, close 8,360, previous close 8,150
- Volume
- 537×10K shares
- 47.2B KRW 3.07× the 20-session average
Market close of 10/21 (Wed)
Where it sits in the 1-year range
26%1-year close range 3,850 to 21,300 won, 26% up from the low
26% of the way up from the lowest close in 1 year (240 sessions) · -60.8% from the high
Something to check
1 to check: more trading value than usual
Free · no sign-inSource from 2021-05-17
Points to check
- Trading valueto check3.1×47.2B KRW, 3.1× the 20-session average3.07× the 20-session average · check threshold 3×
- Earningsnot verifiedThe last four quarters are incomplete, so not verified
- Recent filingsnot verifiedOutside filing data coverage, so not verified
The other 3
- Foreign & institutionalnot verified
- Daily move+2.58%usual range
- Data date10/21 (Wed)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue15.5B KRW
- vs. year ago
- —
- vs. prior quarter
- —
- Operating income929.14 million KRW
- vs. year ago
- —
- vs. prior quarter
- —
- Operating margin6.0%
- vs. year ago
- —
- vs. prior quarter
- —
Quarterly operating income trend
As of the latest official close · 2026-10-21Valuation filing date · 2026-05-15Same sector · 제약
Up +0.83%· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +1.5% | Up +1.87% | 166.1B KRW |
| 셀트리온 | Close over the last 20 sessions +9.6% | Up +0.10% | 119.2B KRW |
| 지투지바이오 | Close over the last 20 sessions +27.6% | Up +13.78% | 49.8B KRW |
| 유한양행 | Close over the last 20 sessions +11.7% | Up +0.46% | 35.3B KRW |
| 한미약품 | Close over the last 20 sessions -26.3% | Up +0.26% | 28.1B KRW |
Schedule
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.